With China in the Rearview, St George Mining Fast-Tracks Brazil’s Araxá as Rare Earths Wildcard”

As geopolitical tensions reshape the global minerals landscape, St George Mining is making a decisive play. The Australia-listed explorer has secured a hefty A$72.5 million in fresh funding to fast-track development of its Araxá rare earths and niobium project in Brazil—at a moment when the West is scrambling to loosen China’s grip on critical mineral…

Read More

Prana Thoracic Secures $9 Million to Revolutionize Lung Cancer Treatment

Prana Thoracic, a medical device company pioneering minimally invasive lung tissue excision, today announced the closing of a $3 million extension to its Series A financing round. The additional funding brings the total capital raised to $9 million. The oversubscribed round reflects strong investor confidence in the company’s innovative approach to addressing early-stage lung cancer. …

Read More

Foundry Launches Cutting-Edge Suite of Products Elevating Cryptocurrency Mining Standards

Foundry Digital LLC (“Foundry”), a leading provider of digital asset infrastructure solutions, has unveiled its latest innovation, Foundry Hardware, aimed at revolutionizing institutional cryptocurrency mining operations. This comprehensive suite of products promises to set new benchmarks in operational performance, efficiency, and reliability within the mining industry. Foundry Hardware addresses critical needs in the cryptocurrency mining…

Read More

Samp Secures €6 Million Funding Round to Revolutionize Industrial Digital Twins

Samp, an innovative player in the industrial technology sector, has successfully closed a €6 million fundraising round aimed at advancing its groundbreaking AI-generated digital twin solution. Founded in 2019 by industry veterans Shivani Shah, a former executive at CEA, and Laurent Bourgouin, previously with Dassault Systèmes, Samp is on a mission to empower industrial sites…

Read More
Jeanne Volatron, Co-Founder and CEO of EVerZom Nicolas Rousseau

EVerZom Secures €10M to Advance Groundbreaking Exosome-Based Biotherapies for Inflammatory Diseases

EVerZom, a pioneering biotechnology firm based in France, has secured €10 million in a Series A funding round to propel the clinical development of its first therapeutic candidate and further scale its exosome biomanufacturing platform. The investment, which brings together major players like Capital Grand Est, the European Innovation Council (EIC) Fund, Sorbonne Venture by…

Read More

Qualifyze Secures $54 Million in Series B Funding to Revolutionize Supplier Risk Management in Life Sciences

In a significant boost for the Life Sciences industry, Qualifyze has announced a landmark $54 million Series B funding round. This investment, led by global software investment firm Insight Partners, alongside existing backers HV Capital, HarbourVest Partners, H14, and Cherry Ventures, is set to propel Qualifyze into a new phase of growth and innovation. With…

Read More

Paris-Based Formality Secures €8 Million to Revolutionize Contract Management

In a significant advancement for the realm of contract management, Formality, a Paris-based platform specializing in intelligent contract management for clients and suppliers, has announced the successful raising of €8 million in its initial funding round. This round was spearheaded by prominent venture capital firms Partech and Serena, alongside an investment of €2.4 million from…

Read More

IdentifAI Secures €2.2M to Combat Deepfake Threats with Advanced Detection Models

Milan-based IdentifAI, a pioneering startup focused on identifying and mitigating deepfake content through cutting-edge technology, has announced a successful seed funding round, raising €2.2 million. This significant investment will fuel the company’s mission to develop sophisticated generative models that distinguish between human-created and AI-generated content. The funding round, led by United Ventures, a venture capital…

Read More

Beacon Therapeutics Raises $170 Million to Propel Ophthalmic Gene Therapy Innovations

Beacon Therapeutics, a pioneering ophthalmic gene therapy company dedicated to combating blinding retinal diseases, has secured $170 million in Series B funding, marking a significant stride towards advancing its transformative treatments. Led by Forbion and supported by existing investors Syncona and Oxford Science Enterprises, alongside newcomers TCGX and Advent Life Sciences, this funding round will…

Read More

Kanvas Biosciences Secures $12.5M to Propel Microbiome-Based Cancer Therapies

Kanvas Biosciences, a pioneering spatial biology company, has announced a significant stride in its mission to revolutionize healthcare with microbiome-based therapies. With an additional $12.5 million in funding co-led by DCVC and Lions Capital LLC, and supported by FemHealth Ventures, Germin8, Ki Tua Fund, and Pangaea Ventures, alongside existing investors, the company’s total funding now…

Read More